Preview

HIV Infection and Immunosuppressive Disorders

Advanced search

Molecular and genetic properties of hepatitis b virus and their clinical role in chronic hepatitis B

https://doi.org/10.22328/2077-9828-2020-12-4-43-50

Abstract

Objective. To study the molecular and genetic properties of hepatitis B virus (HBV) and their relationship with clinical and laboratory parameters in patients with chronic HBV infection.

Materials and methods. The study group included 228 patients with chronic HBV-infection. Routine hematological and biochemical tests, serum HBV DNA level, liver fibrosis (F) stage were measured. The determination of HBV genotype, subtype and drug resistance mutations was carried out by sequencing followed by phylogenetic analysis in 131 patients.

Results. HBV DNA level above 2000 IU/ml was found in 68,4% of patients. The majority of the patients were HBeAg-negative (87,3%), they had viral load lower as compared with those HBeAg-positive (p<0,001). The viral load had a positive correlation with aminotransferases activity and severity of liver fibrosis, and negative correlation with the platelets count, albumin and prothrombin levels. HBV DNA level in patients with advanced liver fibrosis (F2-F4) was significantly higher vs. those with liver fibrosis stage F0-F1 (p=0,001). In patients with viral load above 2000 IU/ml hepatic necrosis, hypoalbuminemia and dysproteinemia were more pronounced. Phylogenetic analysis revealed the circulation of HBV genotypes D (74,8%) and A (23,7%), as well as genotype C and recombinant form D/A/D were detected. Patients with genotype D had higher aminotransferases and gammaglutamiltransferase (p<0,05) levels, and higher proportion of advanced liver fibrosis (F2-F4, p=0,04) vs. those with genotype A; no differences in viral load were found. Antiviral treatment is indicated in 59,2% of patients with genotype D, and only in 38,7% with genotype A (p=0,046).

About the Authors

D. V. Tereshkov
Gomel Regional Infectious Clinical Hospital
Belarus

Dmitriy V. Tereshkov

Gomel



V. M. Mitsura
Gomel State Medical University
Belarus

Victor M. Mitsura

Gomel



E. L. Gasich
Republican Research and Practical Center for Epidemiology and Microbiology
Belarus

Elena L. Gasich

Minsk



References

1. Mitsura V.M., Volchenko A.N., Tserashkou D.V., Zapolskaya V.V. The incidence and dynamics of morbidity from different forms of hepatitis B virus infection in the Republic of Belarus. Clin. infectol. parasitol., 2018, Vol. 7, No. 3, рр. 370–380 (In Russ.).

2. Rajoriya N., Combet C., Zoulim F., Janssen H. How viral genetic variants and genotypes influence disease and treatment outcome of chronic hepatitis B. Time for an individualised approach? // J. Hepatol. 2017. Vol. 67. Р. 1281–1297. doi: 10.1016/j.jhep.2017.07.011.

3. Terrault N.A., Lok A.S., McMahon B.J. et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 Hepatitis B Guidance // Hepatology. 2018. Vol. 67 (4). Р. 1560–1599. doi: 10.1002/hep.29800.

4. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection // J. Hepatol. 2017. Vol. 67. Р. 370–398. doi: 10.1016/j.jhep.2017.03.021.

5. Sarin S.K., Kumar M., Lau G.K. et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update // Hepatol. Int. 2016. Vol. 10. Р. 1–98. doi: 10.1007/s12072-015-9675-4.

6. Kramvis A. Genotypes and genetic variability of hepatitis B virus // Intervirology. 2014. Vol. 57. Р. 141–150. doi: 10.1159/000360947.

7. Tong S., Revill P. Overview of hepatitis B viral replication and genetic variability // J. Hepatol. 2016. Vol. 64. Р. 4–16. doi: 10.1016/j.jhep.2016.01.027.

8. Sunbul M. Hepatitis B virus genotypes: Global distribution and clinical importance // World J. Gastroenterol. 2014. Vol. 20 (18). Р. 5427–5434. doi: 10.3748/wjg.v20.i18.5427.

9. Gasich E.L., Eremin V.F., Nemira A.S. Molecular epidemiology of hepatitis B virus genotypes isolated in Belarus. HIV Infection and Immunosuppressive Disorders, 2016, Vol. 8 (4), рр. 43–54 (In Russ.). doi: 10.22328/2077-9828-2016-8-4-43-54.

10. Ito K., Yotsuyanagi H., Yatsuhashi H. Risk factors for long-term persistence of serum hepatitis B surface antigen following acute hepatitis B virus infection in Japanese adults // Hepatology. 2014. Vol. 59. Р. 89–97. doi: 10.1002/hep.26635.

11. Lin C.-L., Kao J.-H. Hepatitis B virus genotypes and variants // Cold Spring Harb Perspect Med. 2015. Vol. 5. a021436. doi: 10.1101/cshperspect.a021436.

12. Watanabe K., Takahashi T., Takahashi S. Comparative study of genotype B and C hepatitis B virus-induced chronic hepatitis in relation to the basic core promoter and precore mutations // J. Gastroenterol Hepatol. 2005. Vol. 20. Р. 441–449. doi: 10.1111/j.1440-1746.2004.03572.x.

13. Sánchez-Tapias J.M., Costa J., Mas A. et al. Influence of hepatitis B virus genotype on the long-term outcome of chronic hepatitis B in western patients // Gastroenterology. 2002. Vol. 123. Р. 1848–1856. doi: 10.1053/gast.2002.37041.

14. Chulanov V.P., Mamonova N.A., Karandashova I.V. Clinical significance of genetic diversity of hepatitis B virus. Infectious diseases, 2016, Vol. 14 (4), рр. 18–25 (In Russ.). doi: 10.20953/1729-9225-2016-4-18-25.

15. Kuhnhenn L., Jiang B., Kubesch A. Impact of HBV genotype and mutations on HBV DNA and qHBsAg levels in patients with HBeAg-negative chronic HBV infection // Aliment Pharmacol. Ther. 2018. Vol. 47. Р. 1523–1535. doi: 10.1111/apt.14636.

16. Harkisoen S., Arends J.E., van Erpecum K.J. et al. Hepatitis B viral load and risk of HBV-related liver disease: from East to West? // Ann. Hepatol. 2012. Vol. 11 (2). Р. 164–171. doi: 10.1016/S1665-2681(19)31020-8.

17. Caligiuri P., Cerruti R., Icardi G., Bruzzone B. Overview of hepatitis B virus mutations and their implications in the management of infection // World J. Gastroenterol. 2016. Vol. 22. Р. 145–154. doi: 10.3748/wjg.v22.i1.145.


Review

For citations:


Tereshkov D.V., Mitsura V.M., Gasich E.L. Molecular and genetic properties of hepatitis b virus and their clinical role in chronic hepatitis B. HIV Infection and Immunosuppressive Disorders. 2020;12(4):43-50. (In Russ.) https://doi.org/10.22328/2077-9828-2020-12-4-43-50

Views: 741


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2077-9828 (Print)